A Phase I/lb/II Study of Cabozantinib in Combination with Selumetinib for Plexiform Neurofibromas in Adults and Adolescents

PROTOCOL CHAIRS

• Chelsea Kotch, MD MSCE, Chair
• Brian Weiss, MD, Co-Chair